Get the Stockscreener App
7.57
1.05%
-0.08
Pre-market:
7.18
-0.39
-5.15%
Treace Medical Concepts Inc stock is traded at $7.57, with a volume of 232.09K.
It is down -1.05% in the last 24 hours and down -4.42% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
See More
Previous Close:
$7.65
Open:
$7.58
24h Volume:
232.09K
Relative Volume:
0.52
Market Cap:
$471.59M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-7.4056
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-3.81%
1M Performance:
-4.42%
6M Performance:
+12.15%
1Y Performance:
-43.76%
1-Day Range:
$7.36
$7.60
1-Week Range:
$7.36
$8.07
52-Week Range:
$3.92
$15.98
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
7.57 | 471.59M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
114.25 | 198.16B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.95 | 141.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
364.10 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
82.68 | 106.02B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.15 | 43.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Reduced by Geode Capital Management LLC - Defense World
Barclays PLC Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Insiders Of Treace Medical Concepts Are Up 58% On Their US$7.31m Purchase - Simply Wall St
Franklin Resources Inc. Acquires Shares of 36,487 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on Bunion Surgery Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital - Defense World
Lake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy Recommendation - MSN
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday - Benzinga
Treace Medical Concepts (NASDAQ:TMCI) Now Covered by Analysts at Lake Street Capital - MarketBeat
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure - The Manila Times
Treace Medical Launches Groundbreaking Minimally Invasive Bunion Surgery System Targeting 450,000 Annual Procedures - StockTitan
Who Holds the Power? Discover the Forces Behind Treace Medical Concepts! - Jomfruland.net
With 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big guns - Yahoo Finance
State Street Corp Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
10,003 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by HighTower Advisors LLC - Defense World
Stifel Financial Corp Has $776,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.88 Average PT from Brokerages - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Fmr LLC Purchases 54,353 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. announced that it expects to receive $2.1 million in funding - Marketscreener.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
Analysts Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $7.88 - MarketBeat
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings) - Benzinga
Treace Medical Concepts’ (TMCI) Neutral Rating Reaffirmed at JPMorgan Chase & Co. - Defense World
Truist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) Stock - MarketBeat
Treace Medical Concepts' (TMCI) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
TMCITreace Medical Concepts, Inc. Latest Stock News & Market Updates - StockTitan
Treace Medical Concepts, Inc. Announces First Surgical Cases Utilizing SpeedPlate MicroQuad Implant - Marketscreener.com
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant - The Manila Times
Treace Medical Successfully Launches Revolutionary MicroQuad™ Bunion Surgery Implant - StockTitan
Reviewing AVITA Medical (NASDAQ:RCEL) and Treace Medical Concepts (NASDAQ:TMCI) - Defense World
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities - The Manila Times
Treace Medical Launches First-Ever AI-Powered Patient-Specific Bunion Surgery System in US - StockTitan
Further Upside For Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Could Introduce Price Risks After 84% Bounce - Simply Wall St
Treace Appoints Guy Guglielmino as Chief Commercial Officer - The Manila Times
Treace Medical Concepts, Inc. Appoints Guy Guglielmino as Chief Commercial Officer - Marketscreener.com
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times
Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com
Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):